IP Library › Granted Patent US 7,622,496
Granted Patent B2
US 7,622,496 · App. 11/643,192 · Granted Nov 24, 2009

Modified lysine-mimetic compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,622,496
App. No.
11/643,192
Granted
Nov 24, 2009
Kind
B2
Abstract

Lysine mimetic compounds having useful pharmacological activity such as antiarrhythmic activity and desirable bioavailability properties are disclosed.

Claims (8)

1. A compound that is

or a pharmaceutically acceptable salt thereof.

2. A pharmaceutical composition comprising

or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

3. A compound that is

or a pharmaceutically acceptable salt thereof.

4. A pharmaceutical composition comprising

or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Assignments (3)
RELEASE OF SECURITY INTEREST Recorded May 11, 2023
From: ZOOLANDER SA LLC
To: ZEALAND PHARMA A/S
Reel/Frame 063624/0547 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 9, 2011
From: WYETH
To: ZEALAND PHARMA A/S
Reel/Frame 026721/0174 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 5, 2007
From: LARSEN, BJARNE D.; PETERSEN, JORGEN S.; HAUGAN, KETIL J.; BUTERA, JOHN A.; HENNAN, JAMES K.; KERNS, EDWARD H.; PIATNITSKI, EVGUENI L.
To: ZEALAND PHARMA A/S; WYETH
Reel/Frame 018717/0054 →